Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	169.65	99.59	102.83	155.58	42.3	45.9
Short-Term Investments	321.25	617.99	374.54	268.97	154.67	81.74
Cash & Short-Term Investments	490.9	717.58	477.37	424.55	196.97	127.64
Cash Growth	-34.83%	50.32%	12.44%	115.55%	54.31%	375.47%
Receivables	70	-	0.1	0.1	0.45	-
Prepaid Expenses	11.01	20.88	9.01	6.52	2.65	1.97
Other Current Assets	-	-	-	-	0.1	-
Total Current Assets	571.91	738.46	486.48	431.17	200.16	129.61
Property, Plant & Equipment	3.71	3.44	3.34	2.94	2.06	0.79
Other Long-Term Assets	1.52	0.5	0.6	0.98	1.49	0.86
Total Assets	577.14	742.4	490.42	435.09	203.71	131.26
Accounts Payable	10.06	2.14	2.24	14.23	2.33	0.67
Accrued Expenses	39.53	44.83	23.17	18.11	10.4	9.06
Current Portion of Leases	0.73	0.51	0.84	0.61	0.52	0.46
Current Unearned Revenue	0.37	0.29	0.29	0.29	0.29	0.3
Other Current Liabilities	-	0.1	0.1	0.1	0.1	0.19
Total Current Liabilities	50.7	47.87	26.64	33.35	13.64	10.67
Long-Term Debt	20.89	20.58	20.21	4.65	-	-
Long-Term Leases	2.58	2.02	0.99	-	-	-
Long-Term Unearned Revenue	-	0.28	0.57	0.86	1.15	-
Other Long-Term Liabilities	-	-	-	1.17	1.21	0.54
Total Liabilities	74.17	70.76	48.4	40.03	15.99	11.22
Common Stock	0.82	0.81	0.54	0.41	0.24	0.04
Additional Paid-In Capital	1,531	1,478	960.54	741.07	412.1	218.09
Retained Earnings	-1,218	-995.86	-725.91	-488.17	-358.3	-278.89
Comprehensive Income & Other	0.36	-0.01	0.34	-0.39	-0.16	-0.01
Total Common Equity	314.09	482.75	235.51	252.92	53.88	-60.76
Shareholders' Equity	502.97	671.64	442.02	395.06	187.72	120.04
Total Liabilities & Equity	577.14	742.4	490.42	435.09	203.71	131.26
Total Debt	24.2	23.12	22.04	5.26	0.52	0.46
Net Cash (Debt)	466.7	694.47	455.33	419.29	196.45	127.18
Net Cash Growth	-36.07%	52.52%	8.60%	113.44%	54.46%	585.96%
Net Cash Per Share	5.75	10.23	10.17	13.07	16.48	35.76
Filing Date Shares Outstanding	95.44	81.48	62.77	42.9	25.91	7.23
Total Common Shares Outstanding	82.23	80.99	53.99	41.31	23.92	4.23
Working Capital	521.22	690.59	459.84	397.82	186.53	118.94
Book Value Per Share	3.82	5.96	4.36	6.12	2.25	-14.36
Tangible Book Value	314.09	482.75	235.51	252.92	53.88	-60.76
Tangible Book Value Per Share	3.82	5.96	4.36	6.12	2.25	-14.36
Machinery	-	2.25	2.05	2.22	1.4	3.01
Leasehold Improvements	-	0.25	0.67	1.11	0.75	0.74

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q